BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 9816263)

  • 1. Regulation of astrocyte proliferation by prostaglandin E2 and the alpha subtype of protein kinase C.
    Sawada M; Suzumura A; Ohno K; Marunouchi T
    Brain Res; 1993 Jun; 613(1):67-73. PubMed ID: 8348305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of mammalian septin expression in human malignant brain tumors.
    Kim DS; Hubbard SL; Peraud A; Salhia B; Sakai K; Rutka JT
    Neoplasia; 2004; 6(2):168-78. PubMed ID: 15140406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic modeling of glioma formation in mice.
    Begemann M; Fuller GN; Holland EC
    Brain Pathol; 2002 Jan; 12(1):117-32. PubMed ID: 11770894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitogenic signaling and the relationship to cell cycle regulation in astrocytomas.
    Besson A; Yong VW
    J Neurooncol; 2001 Feb; 51(3):245-64. PubMed ID: 11407596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of p21(Waf1/Cip1) in protein kinase C alpha-induced cell cycle progression.
    Besson A; Yong VW
    Mol Cell Biol; 2000 Jul; 20(13):4580-90. PubMed ID: 10848585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic changes in glioblastoma cell lines detected by comparative genomic hybridization.
    Venkatraj VS; Begemann M; Sobrino A; Bruce JN; Weinstein IB; Warburton D
    J Neurooncol; 1998 Jan; 36(2):141-8. PubMed ID: 9525813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analogs of staurosporine: potential anticancer drugs?
    Gescher A
    Gen Pharmacol; 1998 Nov; 31(5):721-8. PubMed ID: 9809468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staurosporine analogues - pharmacological toys or useful antitumour agents?
    Gescher A
    Crit Rev Oncol Hematol; 2000 May; 34(2):127-35. PubMed ID: 10799837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of human glioblastoma cells with the staurosporine derivative CGP 41251 inhibits CDC2 and CDK2 kinase activity and increases radiation sensitivity.
    Begemann M; Kashimawo SA; Heitjan DF; Schiff PB; Bruce JN; Weinstein IB
    Anticancer Res; 1998; 18(4A):2275-82. PubMed ID: 9703866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CGP 41251 and tamoxifen selectively inhibit mitogen-activated protein kinase activation and c-Fos phosphoprotein induction by substance P in human astrocytoma cells.
    Luo W; Sharif TR; Houghton PJ; Sharif M
    Cell Growth Differ; 1997 Nov; 8(11):1225-40. PubMed ID: 9372245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential inhibition of the epidermal growth factor-, platelet-derived growth factor-, and protein kinase C-mediated signal transduction pathways by the staurosporine derivative CGP 41251.
    Andrejauskas-Buchdunger E; Regenass U
    Cancer Res; 1992 Oct; 52(19):5353-8. PubMed ID: 1394140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth inhibition induced by Ro 31-8220 and calphostin C in human glioblastoma cell lines is associated with apoptosis and inhibition of CDC2 kinase.
    Begemann M; Kashimawo SA; Lunn RM; Delohery T; Choi YJ; Kim S; Heitjan DF; Santella RM; Schiff PB; Bruce JN; Weinstein IB
    Anticancer Res; 1998; 18(5A):3139-52. PubMed ID: 9858877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the new selective protein kinase C inhibitor 4'-N-benzoyl staurosporine on cell cycle distribution and growth inhibition in human small cell lung cancer cells.
    Ikegami Y; Yano S; Nakao K
    Arzneimittelforschung; 1996 Feb; 46(2):201-4. PubMed ID: 8720314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the growth of glioblastomas by CGP 41251, an inhibitor of protein kinase C, and by a phorbol ester tumor promoter.
    Begemann M; Kashimawo SA; Choi YA; Kim S; Christiansen KM; Duigou G; Mueller M; Schieren I; Ghosh S; Fabbro D; Lampen NM; Heitjan DF; Schiff PB; Bruce JN; Weinstein IB
    Clin Cancer Res; 1996 Jun; 2(6):1017-30. PubMed ID: 9816263
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.